Disruptions in screening could exacerbate disparities.
Prevention and early detection are critical to our mission. Unfortunately, too many people remain unscreened, and the situation caused by the pandemic is resulting in a decline in cancer screening rates.
In response to these challenges, the American Cancer Society is leveraging our extensive expertise to provide guidance on how public health agencies, health care providers, and screening advocates can promote and deliver cancer screening appropriately, safely, and equitably during the COVID-19 pandemic.
We’ve created a
comprehensive toolkit that includes screening messages and guidance for breast, cervical, colorectal, and lung cancers, as well as HPV vaccination.